News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

Glencore needs some of its own medicine

If anyone still doubts the good times are over for global mining companies, take a look at the latest results for BHP Billiton and Glencore Xstrata

If anyone still doubts the good times are over for global mining companies, take a look at the latest results for BHP Billiton and Glencore Xstrata.

Both are suffering amid the end of the commodities super cycle. BHP on Tuesday reported a 30% drop in earnings to $10.9 billion for the fiscal year ended in June thanks largely to a drop in iron-ore prices. But Glencore slid to an $8.9 billion loss in the first half. That was mainly due to a $7.7 billion write down on the merger it finalised less than four months ago.

WSJ Logo